NCT03266705View on ClinicalTrials.gov

A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood

PHASE1CompletedINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

February 15, 2018

Study Completion Date

March 1, 2018

Conditions

Healthy

Interventions

DRUG

tafamidis

bioequivalence study

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY